Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €1.57B | €1.50B | €1.42B | €1.43B | — | — |
| Research & development | — | — | — | — | €200,000 | — |
| Operating expenses | €181.6M | €151.0M | €150.9M | €154.3M | — | — |
| Operating income | €1.73B | €1.54B | €457.2M | €542.5M | €290.4M | −€811.6M |
| Operating margin | 110.20% | 102.11% | 32.20% | 37.97% | — | — |
| EBITDA | €1.74B | €1.55B | €474.9M | €559.1M | €308.5M | −€791.6M |
| EBITDA margin | 111.26% | 103.25% | 33.44% | 39.14% | — | — |
| Net income | €1.46B | €1.25B | €174.3M | €429.8M | €572.0M | −€931.2M |
| Net profit margin | 93.08% | 83.08% | 12.27% | 30.09% | — | — |
| Basic EPSper basic share | €4.54 | €3.84 | €0.68 | €1.45 | €1.91 | -€2.75 |
| Diluted EPSper diluted share | €4.54 | €3.83 | €0.67 | €1.45 | €1.91 | -€2.75 |